Ying Dong

1PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 14, 2024
First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial.

Tao Li, Ying Dong, Yongzhong Wei

Pageof 1

Frequent Collaborators

1 joint publications

Tao Li

1 joint publications

Yongzhong Wei

1 joint publications

Shoufeng Wang

1 joint publications

Yunxia Liu